53
https://pubmed.ncbi.nlm.nih.gov/38116472
The review discusses the potential of modern biotechnological methods, such as monoclonal antibodies, nanobodies, and small molecules, to develop new, improved types of antivenoms for snakebite envenoming, addressing the limitations of traditional plasma-derived antivenoms.